Jane Yonish
About Jane Yonish
Jane Yonish is the Interim Lead for Immuno-Oncology at Bristol-Myers Squibb, with over 20 years of experience in the field.
Current Role at Bristol-Myers Squibb
Jane Yonish is the Interim Lead of the Immuno-Oncology Integrated Community Oncology Network for US Medical at Bristol-Myers Squibb. She has been in this role since March 2018 and operates out of Sugar Land, TX. Her work involves the integration of community oncology networks, with a strong focus on immuno-oncology.
Associate Director at Bristol-Myers Squibb
Jane Yonish also serves as an Associate Director within the Immuno-Oncology Collaborative Institute (IOCI) Operations at Bristol-Myers Squibb. This role underscores her capacity in operational functions within the highly specialized area of immuno-oncology.
Past Experience at Bristol-Myers Squibb
From 2000 to 2013, Jane Yonish held the position of Executive Medical Science Liaison at Bristol-Myers Squibb. This 13-year tenure highlights her extensive experience and deep roots within the company, especially in the oncology domain.
Education and Expertise
Jane Yonish studied at the University of Minnesota. With over 20 years of experience, she has developed profound expertise in the field of immuno-oncology, particularly in medical science liaison roles. Her educational background has significantly contributed to her proficiency and knowledge in oncology.
Background in Oncology
Jane Yonish has a strong background in medical science liaison roles, focusing on oncology. Her career has been largely dedicated to advancing the field of immuno-oncology, evident from her various roles and long-standing tenure at Bristol-Myers Squibb.